Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors,Expert Review of Clinical Immunology

当前位置： X-MOL 学术 › Expert Rev. Clin. Immunol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Colorectal medullary carcinoma: a pathological subtype with intense immune response and potential to benefit from immune checkpoint inhibitors
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2024-03-08 , DOI: 10.1080/1744666x.2024.2328746
Haoyi Zou ₁ , Chao Liu _{1,

2} , Yuli Ruan _{1,

2} , Lin Fang ₃ , Tong Wu ₁ , Shuling Han ₁ , Tianjiao Dang ₁ , Hongxue Meng ₄ , Yanqiao Zhang _{1,

2,

5}

Affiliation

Different pathological types of colorectal cancer have distinguished immune landscape, and the efficacy of immunotherapy will be completely different. Colorectal medullary carcinoma, accounting for...

中文翻译：